These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 38821767)

  • 1. Clinical Features and Risk Factors for Drug-Induced Liver Injury: A Retrospective Study From China.
    Ma X; Chen Z; An J; Zhang C
    Clin Ther; 2024 Aug; 46(8):597-603. PubMed ID: 38821767
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Liver Injury in COVID-19 Patients with Drugs as Causatives: A Systematic Review of 996 DILI Cases Published 2020/2021 Based on RUCAM as Causality Assessment Method.
    Teschke R; Méndez-Sánchez N; Eickhoff A
    Int J Mol Sci; 2022 Apr; 23(9):. PubMed ID: 35563242
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Incidence and Etiology of Drug-Induced Liver Injury in Mainland China.
    Shen T; Liu Y; Shang J; Xie Q; Li J; Yan M; Xu J; Niu J; Liu J; Watkins PB; Aithal GP; Andrade RJ; Dou X; Yao L; Lv F; Wang Q; Li Y; Zhou X; Zhang Y; Zong P; Wan B; Zou Z; Yang D; Nie Y; Li D; Wang Y; Han X; Zhuang H; Mao Y; Chen C
    Gastroenterology; 2019 Jun; 156(8):2230-2241.e11. PubMed ID: 30742832
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Clinical and pathological features in 138 cases of drug-induced liver injury].
    Lai RT; Wang H; Gui HL; Ye MZ; Dai WJ; Xiang XG; Zhao GD; Wang WJ; Xie Q
    Zhonghua Gan Zang Bing Za Zhi; 2012 Mar; 20(3):185-9. PubMed ID: 22475136
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Drug-induced liver injury in hospitalized patients with notably elevated alanine aminotransferase.
    Xu HM; Chen Y; Xu J; Zhou Q
    World J Gastroenterol; 2012 Nov; 18(41):5972-8. PubMed ID: 23139615
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical characteristics of drug-induced liver injury and primary biliary cirrhosis.
    Yang J; Yu YL; Jin Y; Zhang Y; Zheng CQ
    World J Gastroenterol; 2016 Sep; 22(33):7579-86. PubMed ID: 27672278
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Top-ranking drugs out of 3312 drug-induced liver injury cases evaluated by the Roussel Uclaf Causality Assessment Method.
    Teschke R
    Expert Opin Drug Metab Toxicol; 2018 Nov; 14(11):1169-1187. PubMed ID: 30354694
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Outcomes and Predictors of Mortality in Patients With Drug-Induced Liver Injury at a Tertiary Hospital in South India: A Single-Centre Experience.
    Sunil Kumar N; Remalayam B; Thomas V; Ramachandran TM; Sunil Kumar K
    J Clin Exp Hepatol; 2021; 11(2):163-170. PubMed ID: 33746440
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Drug Induced Liver Injury at a Tertiary Hospital in India: Etiology, Clinical Features and Predictors of Mortality.
    Rathi C; Pipaliya N; Patel R; Ingle M; Phadke A; Sawant P
    Ann Hepatol; 2017; 16(3):442-450. PubMed ID: 28425415
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comprehensive analysis and insights gained from long-term experience of the Spanish DILI Registry.
    Stephens C; Robles-Diaz M; Medina-Caliz I; Garcia-Cortes M; Ortega-Alonso A; Sanabria-Cabrera J; Gonzalez-Jimenez A; Alvarez-Alvarez I; Slim M; Jimenez-Perez M; Gonzalez-Grande R; Fernández MC; Casado M; Soriano G; Román E; Hallal H; Romero-Gomez M; Castiella A; Conde I; Prieto M; Moreno-Planas JM; Giraldez A; Moreno-Sanfiel JM; Kaplowitz N; Lucena MI; Andrade RJ;
    J Hepatol; 2021 Jul; 75(1):86-97. PubMed ID: 33539847
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Real-World Data of Tigecycline-Associated Drug-Induced Liver Injury Among Patients in China: A 3-year Retrospective Study as Assessed by the Updated RUCAM.
    Shi X; Zuo C; Yu L; Lao D; Li X; Xu Q; Lv Q
    Front Pharmacol; 2021; 12():761167. PubMed ID: 34795591
    [No Abstract]   [Full Text] [Related]  

  • 12. Role of liver biopsy in the era of clinical prediction scores for "drug-induced liver injury" (DILI): experience of a tertiary referral hospital.
    Costa-Moreira P; Gaspar R; Pereira P; Lopes S; Canão P; Lopes J; Carneiro F; Macedo G
    Virchows Arch; 2020 Oct; 477(4):517-525. PubMed ID: 32377873
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [RUCAM scale-based diagnosis, clinical features and prognosis of 140 cases of drug-induced liver injury].
    Hao K; Yu Y; He C; Wang M; Wang S; Li X
    Zhonghua Gan Zang Bing Za Zhi; 2014 Dec; 22(12):938-41. PubMed ID: 25654289
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Advances in Idiosyncratic Drug-Induced Liver Injury Issues: New Clinical and Mechanistic Analysis Due to Roussel Uclaf Causality Assessment Method Use.
    Teschke R; Danan G
    Int J Mol Sci; 2023 Jun; 24(13):. PubMed ID: 37446036
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A detection algorithm for drug-induced liver injury in medical information databases using the Japanese diagnostic scale and its comparison with the Council for International Organizations of Medical Sciences/the Roussel Uclaf Causality Assessment Method scale.
    Hanatani T; Sai K; Tohkin M; Segawa K; Kimura M; Hori K; Kawakami J; Saito Y
    Pharmacoepidemiol Drug Saf; 2014 Sep; 23(9):984-8. PubMed ID: 24596340
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Utility of Lymphocyte Transformation Test for Assisting Updated Roussel Uclaf Causality Assessment Method in Drug-Induced Liver Injury: A Case-Control Study.
    Rodríguez A; García-García I; Martínez de Soto L; Gómez López De Las Huertas A; Borobia AM; González-Torbay A; Akatbach-Bousaid I; González-Muñoz M; Ramírez E
    Front Pharmacol; 2022; 13():819589. PubMed ID: 35370653
    [No Abstract]   [Full Text] [Related]  

  • 17. The Indian Network of Drug-Induced Liver Injury: Etiology, Clinical Features, Outcome and Prognostic Markers in 1288 Patients.
    Devarbhavi H; Joseph T; Sunil Kumar N; Rathi C; Thomas V; Prasad Singh S; Sawant P; Goel A; Eapen CE; Rai P; Arora A; Leelakrishnan V; Gopalakrishnan G; Vardhan Reddy V; Singh R; Goswami B; Venkataraman J; Balaraju G; Patil M; Patel R; Taneja S; Koshy A; Nagaraja Rao P; Kumar Sarin S; Rathi P; Dhiman R; Duseja AK; Vargese J; Kumar Jain A; Wadhawan M; Ranjan P; Karanth D; Ganesh P; Nijhawan S; Krishna Dhali G; Adarsh CK; Jhaveri A; Nagral A; Rao P; Shalimar
    J Clin Exp Hepatol; 2021; 11(3):288-298. PubMed ID: 33994711
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Incidence, characteristics and risk factors for drug-induced liver injury in hospitalized patients: A matched case-control study.
    Kong X; Guo D; Liu S; Zhu Y; Yu C
    Br J Clin Pharmacol; 2021 Nov; 87(11):4304-4312. PubMed ID: 33948989
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Drug Induced Liver Injury: Can Biomarkers Assist RUCAM in Causality Assessment?
    Teschke R; Schulze J; Eickhoff A; Danan G
    Int J Mol Sci; 2017 Apr; 18(4):. PubMed ID: 28398242
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Multiple Logistic Regression Model Based on Gamma-Glutamyl Transferase as a Biomarker for Early Prediction of Drug-Induced Liver Injury in Vietnamese Patients.
    Nguyen PTT; Hoang DV; Pham KM; Nguyen HT
    J Clin Pharmacol; 2022 Jan; 62(1):110-117. PubMed ID: 34415063
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.